These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 15662845)
41. Modification of naloxone-induced withdrawal signs by dextromethorphan in morphine-dependent mice. Farzin D Eur J Pharmacol; 1999 Jul; 377(1):35-42. PubMed ID: 10448923 [TBL] [Abstract][Full Text] [Related]
42. Possible involvement of the locus coeruleus in inhibition by prostanoid EP(3) receptor-selective agonists of morphine withdrawal syndrome in rats. Nakagawa T; Masuda T; Watanabe T; Minami M; Satoh M Eur J Pharmacol; 2000 Mar; 390(3):257-66. PubMed ID: 10708732 [TBL] [Abstract][Full Text] [Related]
43. Decrease of tolerance to, and physical dependence on morphine by, glutamate receptor antagonists. González P; Cabello P; Germany A; Norris B; Contreras E Eur J Pharmacol; 1997 Aug; 332(3):257-62. PubMed ID: 9300257 [TBL] [Abstract][Full Text] [Related]
44. Verapamil prevents withdrawal excitation of oxytocin neurones in morphine-dependent rats. Blackburn-Munro G; Brown CH; Neumann ID; Landgraf R; Russell JA Neuropharmacology; 2000 Jul; 39(9):1596-607. PubMed ID: 10854904 [TBL] [Abstract][Full Text] [Related]
45. Withdrawal-induced c-Fos expression in the rat centromedial amygdala 24 h following a single morphine exposure. Jin C; Araki H; Nagata M; Suemaru K; Shibata K; Kawasaki H; Hamamura T; Gomita Y Psychopharmacology (Berl); 2004 Oct; 175(4):428-35. PubMed ID: 15175841 [TBL] [Abstract][Full Text] [Related]
48. The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans. Bisaga A; Comer SD; Ward AS; Popik P; Kleber HD; Fischman MW Psychopharmacology (Berl); 2001 Aug; 157(1):1-10. PubMed ID: 11512037 [TBL] [Abstract][Full Text] [Related]
49. Further evidence for a role of NMDA receptors in the locus coeruleus in the expression of withdrawal syndrome from opioids. Tokuyama S; Zhu H; Oh S; Ho IK; Yamamoto T Neurochem Int; 2001 Aug; 39(2):103-9. PubMed ID: 11408088 [TBL] [Abstract][Full Text] [Related]
50. Glucocorticoid receptor but not mineralocorticoid receptor mediates the activation of ERK pathway and CREB during morphine withdrawal. Navarro-Zaragoza J; Laorden ML; Milanés MV Addict Biol; 2017 Mar; 22(2):342-353. PubMed ID: 26598419 [TBL] [Abstract][Full Text] [Related]
51. Phenylmethanesulfonyl fluoride, a serine protease inhibitor, suppresses naloxone-precipitated withdrawal jumping in morphine-dependent mice. Nemoto W; Sato T; Nakagawasai O; Yaoita F; Silberring J; Tadano T; Tan-No K Neuropeptides; 2013 Jun; 47(3):187-91. PubMed ID: 23290539 [TBL] [Abstract][Full Text] [Related]
53. Morphine acutely and persistently attenuates nonvesicular GABA release in rat nucleus accumbens. Schoffelmeer AN; Wardeh G; Vanderschuren LJ Synapse; 2001 Nov; 42(2):87-94. PubMed ID: 11574945 [TBL] [Abstract][Full Text] [Related]
54. The blockade of GABAA receptors attenuates the inhibitory effect of orexin type 1 receptors antagonist on morphine withdrawal syndrome in rats. Davoudi M; Azizi H; Mirnajafi-Zadeh J; Semnanian S Neurosci Lett; 2016 Mar; 617():201-6. PubMed ID: 26879836 [TBL] [Abstract][Full Text] [Related]
55. A comparison of the effects of clonidine and CNQX infusion into the locus coeruleus and the amygdala on naloxone-precipitated opiate withdrawal in the rat. Taylor JR; Punch LJ; Elsworth JD Psychopharmacology (Berl); 1998 Jul; 138(2):133-42. PubMed ID: 9718282 [TBL] [Abstract][Full Text] [Related]
56. Orexin type 1 receptor antagonism in Lateral Paragigantocellularis nucleus attenuates naloxone precipitated morphine withdrawal symptoms in rats. Ahmadi-Soleimani SM; Ghaemi-Jandabi M; Azizi H; Semnanian S Neurosci Lett; 2014 Jan; 558():62-6. PubMed ID: 24211689 [TBL] [Abstract][Full Text] [Related]
57. Changes in the brain kappa-opioid receptor levels of rats in withdrawal from physical dependence upon butorphanol. Fan LW; Tien LT; Tanaka S; Ma T; Chudapongse N; Sinchaisuk S; Rockhold RW; Ho IK Neuroscience; 2003; 121(4):1063-74. PubMed ID: 14580956 [TBL] [Abstract][Full Text] [Related]
58. Dextromethorphan attenuates morphine withdrawal syndrome in neonatal rats passively exposed to morphine. Yeh GC; Tao PL; Chen JY; Lai MC; Gao FS; Hu CL Eur J Pharmacol; 2002 Oct; 453(2-3):197-202. PubMed ID: 12398904 [TBL] [Abstract][Full Text] [Related]
59. The antinociceptive effect of combined systemic administration of morphine and the glycine/NMDA receptor antagonist, (+)-HA966 in a rat model of peripheral neuropathy. Christensen D; Idänpään-Heikkilä JJ; Guilbaud G; Kayser V Br J Pharmacol; 1998 Dec; 125(8):1641-50. PubMed ID: 9886755 [TBL] [Abstract][Full Text] [Related]
60. Involvement of the bed nucleus of the stria terminalis activated by the central nucleus of the amygdala in the negative affective component of morphine withdrawal in rats. Nakagawa T; Yamamoto R; Fujio M; Suzuki Y; Minami M; Satoh M; Kaneko S Neuroscience; 2005; 134(1):9-19. PubMed ID: 15939543 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]